Study of Abemaciclib with Pembrolizumab in Patients with Stage IV Lung Cancer or Breast Cancer
I3Y-MC-JPCE
Phase 1 other active
Quick answer
Study of Abemaciclib with Pembrolizumab in Patients with Stage IV Lung Cancer or Breast Cancer for Lung Cancer or Breast Cancer is a Phase 1 program (other) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Lung Cancer or Breast Cancer
- Phase
- Phase 1
- Modality
- other
- Status
- active